The latest results show that one pharmacy group's contribution to revenue is more than 30% of the total. This is a rather high exposure when margins are tightening. PBS reforms are projected to soon take a sizeable cut out of many customers cash flow & profits. Seems a bit tight on wiggle room so I'm still cautious.
Comment only (no longer a holder). DYOR.
Add to My Watchlist
What is My Watchlist?